Adrenocortical Carcinoma

Questions discussed in this category

Do you offer postoperative radiation for adrenocortical carcinoma?

If so, how would you design and deliver the treatment?

1 Answer available

Would you offer immunotherapy first line for patients with adrenocortical carcinoma outside of a clinical trial?

The phase 2 trial of pembrolizumab in JCO 2019 showed efficacy, and I have patients preferring to avoid chemotherapy.

2 Answers available

Papers discussed in this category

American journal of clinical oncology, 1991-04

Radiation therapy for adjunctive treatment of adrenal cortical carcinoma.

Annals of surgical oncology, 2018-07

Adjuvant Radiation is Associated with Improved Survival for Select Patients with Non-metastatic Adrenocortical Carcinoma.

Cancer,

Radiotherapy in adrenocortical carcinoma.

J Clin Endocrinol Metab, 2006 Aug 08

Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma.

J Cancer Res Ther,

Adjuvant radiotherapy after surgical resection for adrenocortical carcinoma: A systematic review of observational studies and meta-analysis.

J Clin Endocrinol Metab,

Adjuvant Radiation Improves Recurrence-Free Survival and Overall Survival in Adrenocortical Carcinoma.

J Endocr Soc, 2019 Oct 11

Response to Immunotherapy in Combination With Mitotane in Patients With Metastatic Adrenocortical Cancer.

J Clin Oncol, 2020 Jan 1

PD-1 Blockade in Advanced Adrenocortical Carcinoma.

Related Topics